The idea was reinforced by the observation that when GHRP was administered concomitantly with GHRH, its effect to elevate circulating GH was not simply additive to the anticipated responses of GHRH or that of its truncated analog, sermorelin
It acts by mimicking a natural hormone that regulates appetite, leading to decreased food intake and subsequent weight loss
In contrast, SGLT2 inhibitor monotherapy is not likely to provide sufcient weight loss for treatment of obesity per se, but could have other benefts in obese patients with comorbidities such as atherosclerotic cardiovascular disease, heart failure, or renal disease
Thankfully, my new general practitioner helped me access a generic version (tirzepatide)
High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans